These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23747016)

  • 1. Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.
    Chen D; Kon N; Zhong J; Zhang P; Yu L; Gu W
    Mol Cell; 2013 Jul; 51(1):46-56. PubMed ID: 23747016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ARF tumor suppressor: keeping Myc on a leash.
    Gregory MA; Qi Y; Hann SR
    Cell Cycle; 2005 Feb; 4(2):249-52. PubMed ID: 15655352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
    Chen D; Shan J; Zhu WG; Qin J; Gu W
    Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p19ARF directly and differentially controls the functions of c-Myc independently of p53.
    Qi Y; Gregory MA; Li Z; Brousal JP; West K; Hann SR
    Nature; 2004 Oct; 431(7009):712-7. PubMed ID: 15361884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
    Chen D; Yoon JB; Gu W
    Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMI mediates transcription-independent ARF regulation in response to cellular stresses.
    Li Z; Hou J; Sun L; Wen T; Wang L; Zhao X; Xie Q; Zhang SQ
    Mol Biol Cell; 2012 Dec; 23(23):4635-46. PubMed ID: 23034180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
    Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
    J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
    Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
    Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Myc function by ARF: checkpoint for Myc-induced oncogenesis.
    Sarkar D; Fisher PB
    Cancer Biol Ther; 2006 Jun; 5(6):693-5. PubMed ID: 16775430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
    Qi CF; Kim YS; Xiang S; Abdullaev Z; Torrey TA; Janz S; Kovalchuk AL; Sun J; Chen D; Cho WC; Gu W; Morse Iii HC
    Int J Mol Sci; 2012; 13(5):6204-6219. PubMed ID: 22754359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF.
    Lo D; Zhang Y; Dai MS; Sun XX; Zeng SX; Lu H
    Oncogene; 2015 Mar; 34(13):1688-97. PubMed ID: 24769896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Myc-nucleophosmin-ARF network: a complex web unveiled.
    Li Z; Hann SR
    Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling ARF stability: new players added to the team.
    Tavana O; Chen D; Gu W
    Cell Cycle; 2014; 13(4):497-8. PubMed ID: 24419106
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF.
    Ko A; Han SY; Choi CH; Cho H; Lee MS; Kim SY; Song JS; Hong KM; Lee HW; Hewitt SM; Chung JY; Song J
    Cell Death Differ; 2018 Jun; 25(6):1050-1062. PubMed ID: 29472714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARF differentially modulates apoptosis induced by E2F1 and Myc.
    Russell JL; Powers JT; Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
    Mol Cell Biol; 2002 Mar; 22(5):1360-8. PubMed ID: 11839803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
    Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.
    Tago K; Funakoshi-Tago M; Itoh H; Furukawa Y; Kikuchi J; Kato T; Suzuki K; Yanagisawa K
    Oncogene; 2015 Jan; 34(3):314-22. PubMed ID: 24469041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.
    Wang X; Zha M; Zhao X; Jiang P; Du W; Tam AY; Mei Y; Wu M
    Nat Commun; 2013; 4():1551. PubMed ID: 23462994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.